Republicans seek political advantage by calling Mexican cartels "terrorist organizations," the FDA eases rules for groups distributing the opioid overdose reversal drug nalxone, and more.
Signature-gatherers are criss-crossing the Cowboy State for a pair of marijuana initiatives, the DEA uncharacteristically backs off from some new prohibitions, and more.
The opium poppy is an economic mainstay in Afghanistan. Can the Taliban really suppress it? (UNODC)
On April 3, the Taliban announced a ban on drug cultivation in Afghanistan, for years the world's dominant opium producer, accounting for more than 80 percent of the global supply
Afghanistan has been by far the world's leading supplier of opium for the past 20 years, but now the Taliban say they are going to stop it. Will they? Can they?
After years of delay, Maine regulators say retail marijuana outlets will be open in October, eight people were killed in a Colombian region where different leftist guerrillas are fighting each other for control of the drug trade, and more.
We're looking at 2019 through the rearview mirror now, but before we turn our sights to 2020, it's worth taking a few moments to look back at the last year in international drug policy.